Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol/AKVANO Spray in Mild to Moderate Plaque Psoriasis
NCT05174598Phase 3Completed
- Sponsor
- Cadila Pharmaceuticals
- Start
- Oct 2018
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of AKP01 in plaque psoriasis, sponsored by Cadila Pharmaceuticals. Started Oct 2018; status: completed.
02
Drugs
AKP01
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05174598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05174598.